tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Acadia Pharmaceuticals price target raised to $37 from $32 at H.C. Wainwright
PremiumThe FlyAcadia Pharmaceuticals price target raised to $37 from $32 at H.C. Wainwright
30d ago
Acadia Pharmaceuticals announces FDA approval of Daybue Stix for oral solution
Premium
The Fly
Acadia Pharmaceuticals announces FDA approval of Daybue Stix for oral solution
1M ago
Acadia Pharmaceuticals price target raised to $25 from $24 at Stifel
Premium
The Fly
Acadia Pharmaceuticals price target raised to $25 from $24 at Stifel
1M ago
ACADIA Pharmaceuticals: Strong Growth Prospects and Strategic Positioning Justify Buy Rating
PremiumRatingsACADIA Pharmaceuticals: Strong Growth Prospects and Strategic Positioning Justify Buy Rating
2M ago
ACADIA Pharmaceuticals: Hold Rating Amid Stable U.S. Performance and Growth Potential
Premium
Ratings
ACADIA Pharmaceuticals: Hold Rating Amid Stable U.S. Performance and Growth Potential
2M ago
ACADIA Pharmaceuticals: Hold Rating Amid Growth Prospects and Uncertainties
Premium
Ratings
ACADIA Pharmaceuticals: Hold Rating Amid Growth Prospects and Uncertainties
2M ago
Acadia Pharmaceuticals sees FY25 revenue $1.07B-$1.095B, consensus $1.07B
PremiumThe FlyAcadia Pharmaceuticals sees FY25 revenue $1.07B-$1.095B, consensus $1.07B
2M ago
ACAD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ACAD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ACADIA Pharmaceuticals Advances Alzheimer’s Disease Psychosis Study with ACP-204
Premium
Company Announcements
ACADIA Pharmaceuticals Advances Alzheimer’s Disease Psychosis Study with ACP-204
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100